<DOC>
	<DOCNO>NCT01284829</DOCNO>
	<brief_summary>This prospective study aim validate new diagnostic approach tissue characterization adrenal tumor indeterminate conventional imaging . For purpose , necessary control group since diagnostic accuracy well defined subset patient . Visit 0 : Enrollment , eligibility . Visit 1 : FDG-PET . Visit 2 : Postoperative visit . Visit 3 : 6 month post-PET . Visit 4 : 12 month post-PET .</brief_summary>
	<brief_title>Performance 18F-Fluorodeoxyglucose Positron Emission Tomography ( FDG-PET ) Diagnosis Indeterminate Adrenal Tumors Conventional Imaging : A French Prospective Multicentric Study</brief_title>
	<detailed_description>Primary objective The primary objective ass diagnostic accuracy FDG-PET , particularly SUVmax tumor/liver ratio , diagnosis indeterminate adrenal tumor conventional imaging . Secondary objective - To assess diagnostic accuracy tumor SUVmax , SUVmax tumor/mean SUV liver . - To evaluate relationship SUVmax tumor/liver ratio Weiss score . - To evaluate impact use FDG-PET treatment option . - To evaluate economic impact FDG-PET management indeterminate adrenal tumor ( ancillary study ) .</detailed_description>
	<mesh_term>Adrenal Gland Neoplasms</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Adult â‰¥ 18 yr , male female ; Indeterminate adrenal tumor ( 6.3.1. ) . The CT must include calculation SD contrast washout perform within 30 day inclusion visit ( visit 0 ) ; Patient insure public health care system ; Patient accept participate study sign consent document form . Technical inability perform FDGPET . Patient 's death final diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>